NCT03056872View on ClinicalTrials.gov

Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

May 12, 2023

Study Completion Date

May 12, 2023

Conditions
Alcohol Use DisorderAnxiety Disorder/Anxiety StateStress DisorderHypothalamic Pituitary AdrenalDrinking to Cope
Trial Locations (1)

55454

University of Minnesota Fairview Riverside, Minneapolis

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Minnesota

OTHER

NCT03056872 - Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes | Biotech Hunter | Biotech Hunter